ABCSG 48/POSITIVE Summary

A study evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy.

Start: 11/2017
Coordinating Investigators: Bjelic-Radisic, Vesna; Graz
Sample size: 500 (international), 30 (national)
Design:
(Click to open>
Design ABCSG 48/POSITIVE